Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rubens B. Costa"'
Autor:
Ricardo Costa, Rubens B. Costa-Filho, Sarah M. Talamantes, Fernando Queiroga Jr, Emmanuel C. Campello, Henrique Cartaxo, Rubens B. Costa
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 2, Pp 524-530 (2017)
Interstitial lung disease is a rare complication of trastuzumab-based breast cancer treatment with few case reports published. Herein, we report the case of a 67-year-old female with early-stage HER2-postitive breast cancer who developed interstitial
Externí odkaz:
https://doaj.org/article/78f1c06bd00e43f5bb9cef94f9ae1d89
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 3, Pp 992-997 (2017)
Breast cancer is the most common tumor among women, and approximately 6% of the patients have de novo metastatic breast cancer. Occult breast cancer accounts for only 0.1–0.8% of the cases and most commonly presents with axillary lymphadenopathy. S
Externí odkaz:
https://doaj.org/article/ce36b201180440fab6018e8582001770
Autor:
Sarki A. Abdulkadir, Francis J. Giles, Young K. Chae, Massimo Cristofanilli, Siraj M. Ali, Julia A. Elvin, Laurie Gay, Jeffrey S. Ross, Timothy M. Kuzel, Richard B. Lanman, Rebecca J. Nagy, Rubens B. Costa, Ximing J. Yang, HuiYing Han, Kenji Unno, Vinay Sagar, Ami N. Shah, Sahithi Pamarthy, Benedito A. Carneiro
Figure S1 ALK genomic alterations and mRNA expression in human cancers. Figure S2 Efficacy of ALK inhibitors in prostate cancer cell lines. Table S1 Summary of mutations and their percentages identified by ctDNA profiling.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b1a8d1b8fbbd18b54d0ed1b4de078e1
https://doi.org/10.1158/1078-0432.22474914.v1
https://doi.org/10.1158/1078-0432.22474914.v1
Autor:
Sarki A. Abdulkadir, Francis J. Giles, Young K. Chae, Massimo Cristofanilli, Siraj M. Ali, Julia A. Elvin, Laurie Gay, Jeffrey S. Ross, Timothy M. Kuzel, Richard B. Lanman, Rebecca J. Nagy, Rubens B. Costa, Ximing J. Yang, HuiYing Han, Kenji Unno, Vinay Sagar, Ami N. Shah, Sahithi Pamarthy, Benedito A. Carneiro
Purpose: Small cell carcinoma of the prostate (SCCP) is an aggressive disease that can arise de novo or by transdifferentiation from prostate adenocarcinoma. Alterations in anaplastic lymphoma kinase (ALK) gene are involved in neuroblastoma, lung can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d5214bf1fbee91715c0ba541ca1ed4c
https://doi.org/10.1158/1078-0432.c.6528936
https://doi.org/10.1158/1078-0432.c.6528936
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 10, Iss 3, Pp 992-997 (2017)
Case Reports in Oncology, Vol 10, Iss 3, Pp 992-997 (2017)
Breast cancer is the most common tumor among women, and approximately 6% of the patients have de novo metastatic breast cancer. Occult breast cancer accounts for only 0.1–0.8% of the cases and most commonly presents with axillary lymphadenopathy. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::867b8ac05be730ee8231a40948b4acd9
http://europepmc.org/articles/PMC5731106
http://europepmc.org/articles/PMC5731106
Autor:
Benedito A, Carneiro, Sahithi, Pamarthy, Ami N, Shah, Vinay, Sagar, Kenji, Unno, HuiYing, Han, Ximing J, Yang, Rubens B, Costa, Rebecca J, Nagy, Richard B, Lanman, Timothy M, Kuzel, Jeffrey S, Ross, Laurie, Gay, Julia A, Elvin, Siraj M, Ali, Massimo, Cristofanilli, Young K, Chae, Francis J, Giles, Sarki A, Abdulkadir
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 24(12)
PURPOSE: Small cell carcinoma of the prostate (SCCP) is an aggressive disease that can arise de novo or by transdifferentiation from prostate adenocarcinoma. Alterations in anaplastic lymphoma kinase (ALK) gene are involved in neuroblastoma, lung can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d76f977821ca71c6526e6803b6d9fcb5
https://pubmed.ncbi.nlm.nih.gov/29559559
https://pubmed.ncbi.nlm.nih.gov/29559559